PRESENTED BY EVALUATING BIOPHARMA
Advances in manufacturing 4.0 including digitalization, AI, and machine learning offer biopharmaceutical company’s unique opportunities to overhaul antiquated processes to increase productivity, flexibility, and reduced cost. However, as with each great innovation, there are risks, uncertainties, and challenges. Our experts share their individual experiences and insight to help your anticipate challenges and implement better manufacturing strategies to accelerate success.

https://cii.dryfta.com/eid/168/pid/4